Last reviewed · How we verify
NCT05377086
Structured 3D Exercise and the Conventional Exercise Program for Scoliosis in Children With Rheumatic Disease
NA trial testing Schroth 3-Dimensional scoliosis exercise in Scoliosis in 50 participants. Completed in 1 February 2023.
15 December 2022
Quick facts
| Lead sponsor | Biruni University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 17 May 2022 |
| Primary completion | 15 December 2022 |
| Estimated completion | 1 February 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Schroth 3-Dimensional scoliosis exercise
- conventional scoliosis exercise
Conditions studied
- Scoliosis — all drugs for Scoliosis →
- Juvenile Idiopathic Arthritis — all drugs for Juvenile Idiopathic Arthritis →
Sponsor
Biruni University
Who can join
Adults 8 to 16, any sex, with Scoliosis or Juvenile Idiopathic Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Usage including cases followed up with rheumatism diagnosis and treatment in Istanbul University-Cerrahpasa Medical Faculty Pediatric Rheumatology Clinic, Physiotherapy and Rehabilitation Unit. The study included 50 patients with a spinal x-ray scoliosis problem, aged 8-16 years, who were diagnosed with rheumatism at least 6 months ago, whose medical treatment was stable, Risser 0-4 and exercise indication (Cobb = 10-45ͦ). Patients with additional neurological diagnosis against rheumatism, who have received any previous treatment for a spine problem, who have a mental state and who do not have the consent of their family will not be included. The cases will be divided into 2 groups by method. In the first group (n = 25), structured 3-dimensional scoliosis exercises are taught in the clinic, and the second group (n = 25) is taught conventional physiotherapy applications (posture-core applications-bennet protocols) in the clinic, and both groups are followed by the WTE method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05377086
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Scoliosis
Currently open trials in the same condition.
- NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
- NCT07059663 — Synergic Effects of Schroth Method With and Without Core Stabilization Exercises in Idiopathic Scoliosis Patients · NA · recruiting
- NCT06540885 — A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery · Phase 4 · recruiting
- NCT06242821 — Yoga for Back Pain in Adolescent Scoliosis · NA · recruiting
- NCT06451562 — Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery · NA · recruiting
Other Biruni University trials
Trials by the same sponsor.
- NCT07509762 — Exercise Programs in Women With PCOS · NA · not yet recruiting
- NCT07499843 — Synchronous vs. Asynchronous Telerehabilitation for High-Risk Infants · NA · not yet recruiting
- NCT07495540 — Comparison of the Effects of Free Weight and Machine-Based Exercises on Muscular Parameters · NA · not yet recruiting
- NCT07452328 — Postural Stability and Trunk Strength in Wrestlers · not yet recruiting
- NCT07467525 — Neuromuscular Effects of Acute Fatigue in Adolescent Basketball · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05377086 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biruni University
- Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377086.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing